Low-dose CT for lung cancer screening with Veolity LungRead - made in Germany

In Germany, a program for the early detection of lung cancer in smokers is expected in the future. For medical professionals, software support with AI-based algorithms can play an important role in this complex endeavor.

MeVis is pleased to present Veolity, its all-in-one solution for lung cancer screening, at this year's industry exhibition at the 105th German Radiology Congress (ROEKO). Veolity has been used worldwide for many years in various lung cancer screening programs and in the diagnostic clarification of round foci. Clinicians benefit from AI-based CAD for better lung nodule detection, volumetric measurements, automated growth assessment, German structured Lung-RADS reporting including volumetry and an automated workflow that can reduce reading times compared to a PACS viewer. All available in German language.

MeVis' offering is complemented by an established and integrated third-party-solution for organizing a lung cancer screening program. The following areas are covered:

  • Client registration and recruitment
  • Ressource planning (premises, personnel, and CT scanner)
  • Client invitation system
  • Reporting after successful case reading using Veolity
  • Analysis and statistics for your program

Visit us at our booth no. South-09. We look forward to seeing you!


RheinMain CongressCenter (RMCC)
Friedrich-Ebert-Allee 1
65185 Wiesbaden